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ABSTRACT
Nitrobenzene  is  a  nitrite  compound;  its  toxic  effects  are  due  to  its  ability  to  convert  hemoglobin to
methaemoglobin by  oxidizing  iron.  The  clinical features  of  nitrobenzene  poisoning vary  based on the
concentration of methaemoglobin in blood. Immediate identification based on clinical features, odour of the
compound with supporting evidence of increased methaemoglobin levels will help in a timely intervention thus
preventing fatal outcome.  Early haemodynamic and ventilator support along with administration of methylene
blue as an antidote has been proved crucial in saving some lives. An acute nitrobenzene poisoning presenting with
methaemoglobinemia is becoming quite common in this part of the country. Here authorsreport a series of cases
of nitrobenzene poisoning where immediate clinical evaluation, with repeated intravenous methylene blue saved
three patients, but two patients presenting late and with heavy exposure could not be saved.
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INTRODUCTION
Nitrobenzene is a synthetic organic yellow oily liquid
with an odour resembling bitter almonds. It is widely
used in  agriculture  in this part  of the country  as  a
plant energizer, flowering stimulant and yield booster
in  variable  percentages  for  the  crops  like  tomato,
brinjal,  paddy, chilies,  fruits,  pulses  and  flowering
crops. It is also used in manufacturing of dyes, inks
and shoe polishes.
1,2The toxic effects of nitrobenzene
is  due  to  its  ability  to convert haemoglobin  to
methaemoglobin by oxidizing iron.
3 The fatal dose of
undiluted  nitrobenzene  is  said  to  be  about  fifteen
drops. Death usually occurs within six to seven hours
of ingestion. Nitrobenzene poisoning is on the rise,
due  to  easy access to  products  containing
nitrobenzene.
CASE REPORT
Case  report  1: A 65  year  old  female  came  with
history  of consumption  of  about  30  ml  of  20%
nitrobenzene [Brand name: Boom Plus(micronutrient
for plants)] two hours prior to admission. She had a
history of  four episodes  of  vomiting  after
consumption. On examination, she was conscious and
oriented; cyanosis was present, pulse rate- 80 b/m, BP
-140/80  mm  Hg,  SpO2 on  pulse  oximeter-85%  on
100% oxygen.  Stomach  wash  was  given  with
activated  charcoal  in  the  casualty.  Investigation
showed  Hb-12.2gm/dl,  TLC-26.900cells/mm
3,
platelets-3.18 lakhs/mm
3 and her RFT, LFT, chest X
ray, ECG were all normal. ABG at admission showed
pH  7.33,  PaCo2 27,  PaO2 60,  HCO316.3,  O2Sa -
80%.Methaemoglobin level -17%, she had respiratory
distress and saturation started falling still further, so
she was intubated and put on a mechanical ventilator.
We had to wait for six hours to give IV methylene
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blue as it was not readily available in our hospital, but
meanwhile IV vitamin C 500mg was given. She was
administered  IV  methylene  blue  50  mg as  a  1%
solution over five minutes after six hoursof admission
and  immediatelyher  SpO2 improved  to  92%,  which
dropped later, when 30 mg IV methylene blue was
repeated. With fluctuating symptoms, IV methylene
blue (50 mg TID) and IV ascorbic acid (500 mg OD)
was  continued  for  four  days. The  patient was
extubated on the fourth day and was discharged after
10 days.
Case report 2: A 58 year old male presented with h/o
consumption  of  20  ml  of  a  compound  named
AMRUTH which contained nitrobenzene as 50% of
its constituents around two hours prior to admission.
O/E:  patient  was  restless, tachyapneic,  central
cyanosis was present, pulse rate 94- b/m, BP- 140/90
mmHg, SpO2-85% with high flow O2. Investigations
showed  Hb-14.3gm/dl, TLC-9,300cells/mm
3,
platelets-1.96lacs/mm
3, ABG showed pH 7.44, PaO2
60,  PaCO2 28,  HCO3 20, methaemoglobin  levels -
25%, RFT, LFT, chest X ray, ECG were all normal.
He  was  given  IV  methylene  blue  50  mg  as  a  1%
solution over five minutes and 50 mg IV TID for 2
days. His symptoms and Sp02 improved immediately
after giving the first dose of methylene blue. He was
also supplemented with IV ascorbic acid 500mg OD;
patient improved symptomatically and got discharged
5 days later.
Case report 3: A 22 year lady was referred from a
primary health centre to our casualty with history of
consumption of around 150 ml of 20% nitrobenzene
(Boom  plus) sixhours  prior  to  admission  with
complaints of ten episodes of vomiting, drowsiness
and  breathlessness. O/E she  was  unconscious,
gasping  for  breath,pupils  were  semi  dilated  and
sluggishly reacting to light, had central and peripheral
cyanosis, pulse rate -120b/min, BP-90mmHg systole,
SPO2 -74% with  10  liters  of  oxygen, she  was
immediately intubated and connected to mechanical
ventilator.  Investigations  Hb– 9gm%,  TLC-
12000cells/mm
3,  platelet  count- 2.5lakhs/mm
3,
methaemoglobin  level  was  70%.  ABG    pH- 7.12,
HCO3-12,PaO2 -76,PaCO2- 38,ECG  showed  sinus
tachycardia, RFT, LFT and chest  X  ray  were  all
normal. Inj methylene blue IV 50mg as 1% solution
was  given,  after  one  hour  repeat  ABG  showed  pH
7.10,  PaO2 80mmHg,  PaCO2 50mmHg,
HCO38,suggesting  persistent  metabolic  acidosis,  so
Inj methylene blue IV 50mg was repeated. Over next
two dayspatient didn’t regain her consciousness, inj
methylene blue 50 mg IV TID was continued and she
expired on third day of admission.
Case  report  4:  A  35  year  old  female  patient
presented  with  history  of ten episodes  of  vomiting
and breathlessnessshe  was referred  from  local
hospital  after  gastric  lavage.  She  had  consumed
around  200  ml  of  20%  nitrobenzene  (brand  name:
“Ranger” used as plant nutrient) for suicidal purpose
sevenhours  prior  to  admission.  O/E  she  was
conscious,  restless,  irritable,  central  and  peripheral
cyanosis,  extremities  were  cold,  pupils  dilated  and
sluggishly reacting to light, pulse rate 110/min, BP
80/60mmHg, SpO2 on pulse oximetry: 74% with 10
liters of oxygen. Investigations Hb -11.5 gm%, TLC-
15, 600cells/mm
3,  platelet  count- 2.61 lakhs/mm
3,
methaemoglobin level-56%. ABG showed pH 7.06,
PaO270, PaCO2 24,  HCO316,  O2Sa -80  %.ECG
showed  sinus  tachycardia,  global  ST segment
depression, T wave inversion and LFT, RFT, chest X-
ray  was  normal.  There  was  no  improvement  in
cyanosis even with high flow oxygen. Inj methylene
blue  IV  50mg  as a  1  %  solution was  given  and
dopamine infusion was started. After one hour repeat
ABG showed pH: 7.02, PaO280, PaCO2 50, HCO310,
suggestive  of  persistent  metabolic  acidosis, so Inj
methylene  blue  IV  50mg  was  repeated  .As  oxygen
saturation  did  not  improveandtachycardia  persisted
the    patient  was  intubated  and  connected  to
mechanical  ventilator.  Twenty four  hours later she
developed sinus bradycardia, had cardiac arrest and
succumbed to death.
Case report 5: A 25 year old lady came with history
of  consumption  of  20%  nitrobenzene  substance
(brand  name-BOOMFLOWER-N  used  as  plant
nutrient)  of  unknown  quantity,  four  hours  prior  to
admission.  O/E  she  was  restless  and  in  altered
sensorium,  pulse  rate  120  /min,  BP  94/60mmHg,
SpO2  on  pulse oximetry  85%  with 4  liters  of
oxygen.Investigations showed  Hb% -8.3gm% ,TLC-
12,400cells/mm
3,platelets-2.95lakhs/mm
3 .Her  RFT,
LFT, Chest X ray and ECG were all normal, ABG
showed  pH  7.02,  PaO2 36,  PaCO2 36,  HCO3 18.7,
O2Sa -80  %,  methaemoglobin  level-28%.  She  had
respiratory distress and saturation started falling still
further,  so  she  had  to  be  intubated  and  put  on a466
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mechanical ventilator. Inj methylene blue IV 50mg as
a  1  %  solution was  given,  later  repeated  after  one
hour  and  continued  tid  for  2  days,  she  was  also
supplemented  with  IV  ascorbic  C  500mg  every  12
hrs.Her consciousness improved over a few hours, the
patient improved symptomatically and was extubated
on the second day and discharged a week later.
DISCUSSION
Nitrobenzene  is oxidizing nitrite  compound.
Nitrobenzene  ingestion  converts  haemoglobin  to
methaemoglobin by oxidizing iron.Normally around
1% of methaemoglobin is present in the blood and if
it  exceeds  more  than  1% it  is  termed
methaemoglobinemia. There  are  two  mechanisms
HMP shunt pathway and diaphorase pathway which
maintain low  levels of  methaemoglobin  in  blood.
4
These  two  enzyme  systems  require  NADH  and
NADPH,  to reduce  methaemoglobin  to  its  original
ferrous state. In a condition where there is excessive
oxidative  stress  like  in nitrobenzene passing it will
result in an increased methaemoglobin level, which is
more  than  the  capacity  of  the  body  to  reduce it
through the above two enzyme systems. The lethal
dose  in adults is about      2  to  6 gm.
5 A  normal
individual will  be  symptomatic  only  when the
methemoglobin level is more than 10% and present
with symptoms of headache, fatigue and nausea. At
methaemoglobin level of 30 -40 % patient will have
symptoms of dyspnoea on exertion, palpitation and
lethargy. At methaemogloin  level of  40%  to  70%
patient  will  have  seizures,  coma, lactate acidosis,
respiratory  distress  and arrhythmias. Levels  greater
than 70% will lead to death.
5, 6Clues for diagnosis are
history of  consumption of  chemical  compound,
characteristic  smell  of  bitter  almonds,  persisting
cyanosis even while on oxygen therapy and normal
oxygen saturation  on ABG  (calculated). Blood
collected in syringe will be dark brown in appearance
and will turn chocolate red colour after drying on a
blotting paper.
Treatment: Decontamination,  haemodynamic
support and ventilator management. Methylene blue
is  the specific antidote  for  methaemoglobinemia
induced by nitrobenzene poisoning. Methylene blue
is  administered    if methemoglobin  levels  are  more
than 20%
5and it is infused intravenously at a dose of
1 – 2 mg/kg (max up to 50 mg/ dose in adults) as a
1% solution over five minutes. Injection methylene
blue  should  be  repeated  after  one  hour  if
methaemoglobin levels are high and the patient is still
symptomatic.Maximum dose of 7 mg/kg over 24
hours can be used, in doses of more than 7 mg/kg
methylene  blue  itself may  induce
methaemoglobinemia.
7,8 Ascorbic acid, an antioxidant
can also be administered when methemoglobin levels
are more than 20%.
7
In the first three patients we have observed that the
quantity  consumed  was  less  and  also  admission  to
hospital  after  consumption  was  early,  but in
thelattertwo patient amount consumed was more and
hospitalization was delayed that could have been the
probable reason  for  death.It  was  observed  that
ingestion of nitrobenzene causes very high oxidative
stress as shown by increased methaemoglobin levels.
In severe poisoning administration of methylene blue
will slightly decrease the level of methaemoglobin on
first day, but the levels will rise again high on second
day  due  to  release  of  nitrobenzene  from
gastrointestinal tract  and adipose tissue stores which
may be responsible for the deteriorationof patients.
4
CONCLUSION
The authors here wish to point out that nitrobenzene
poisoning  can  be  managed  successfully  with
intravenous  methylene  blue  and  ascorbic  acid  with
intensive  hemodynamic  and  cardiopulmonary
support, but patients presenting late and with heavy
exposure, the chances of survival are less.
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